CVE-2026-53822
OpenClaw pre-2026.5.18 permits argv-based command injection bypassing allowlist.
Is CVE-2026-53822 being exploited?
Not confirmed. CVE-2026-53822 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 1.1% probability of exploitation in the next 30 days.
How severe is CVE-2026-53822?
CVE-2026-53822 is rated High. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-53822?
Yes. A fix has been recorded for CVE-2026-53822. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-53822 affect?
CVE-2026-53822 affects OpenClaw (pre-2026.5.18). Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-53822?
Upgrade to 2026.5.18+; verify argv handling.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Bypass allowlist via argv manipulation to execute unapproved commands, enabling potential remote/local code execution.
Patch when possible
- affected< 2026.5.18
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.